Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on procedural ...

Cars today are safer than ever. There’s no debate. The amount of safety technology built into ever new vehicle is incredible. The chances of surviving a collision are higher than ever. But so are the ...